The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-acetyl-6-amino-2-((S)-4-guanidino-2-(propylamino)butanamido)hexanamide bis(2,2,2-trifluoroacetate) ID: ALA4852133
PubChem CID: 164616775
Max Phase: Preclinical
Molecular Formula: C20H35F6N7O7
Molecular Weight: 371.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCN[C@@H](CCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NC(C)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C16H33N7O3.2C2HF3O2/c1-3-9-20-12(7-10-21-16(18)19)14(25)23-13(6-4-5-8-17)15(26)22-11(2)24;2*3-2(4,5)1(6)7/h12-13,20H,3-10,17H2,1-2H3,(H,23,25)(H4,18,19,21)(H,22,24,26);2*(H,6,7)/t12-,13-;;/m0../s1
Standard InChI Key: CXZJZTUWHZBXFL-NJHZPMQHSA-N
Molfile:
RDKit 2D
40 37 0 0 0 0 0 0 0 0999 V2000
34.3899 -31.6270 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.9851 -30.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5758 -31.6244 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.6933 -30.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2769 -30.5118 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.6933 -29.6940 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4016 -30.9206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1103 -28.3016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8262 -27.8891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5419 -29.1266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.5419 -28.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8262 -27.0641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5419 -26.6516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2537 -27.8891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9696 -28.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6854 -27.0641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.6854 -27.8891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9696 -29.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6854 -29.5391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6854 -30.3642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3971 -30.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3971 -31.6017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3971 -28.3016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.1130 -27.8891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8289 -28.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1130 -27.0641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9648 -27.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3965 -27.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6806 -28.3032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5427 -25.8266 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2575 -25.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2582 -24.5896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9717 -25.8278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9315 -25.2109 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.5267 -24.5047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1175 -25.2083 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.2350 -24.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8185 -24.0958 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.2350 -23.2780 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9431 -24.5047 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
2 4 1 0
2 5 1 0
4 6 2 0
4 7 1 0
11 14 1 0
17 23 1 0
8 9 1 0
9 11 1 0
11 10 2 0
9 12 1 1
12 13 1 0
14 15 1 0
15 17 1 0
17 16 2 0
15 18 1 6
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
23 24 1 0
24 25 1 0
24 26 2 0
28 8 1 0
28 29 1 0
29 27 1 0
13 30 1 0
30 31 1 0
31 32 1 0
31 33 2 0
35 34 1 0
36 35 1 0
35 37 1 0
35 38 1 0
37 39 2 0
37 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.49Molecular Weight (Monoisotopic): 371.2645AlogP: -1.50#Rotatable Bonds: 13Polar Surface Area: 175.22Molecular Species: BASEHBA: 6HBD: 7#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 9#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.49CX Basic pKa: 12.14CX LogP: -2.97CX LogD: -7.82Aromatic Rings: ┄Heavy Atoms: 26QED Weighted: 0.12Np Likeness Score: 0.22
References 1. Weinhart CG, Wifling D, Schmidt MF, Neu E, Höring C, Clark T, Gmeiner P, Keller M.. (2021) Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2 R selectivity., 213 [PMID:33571911 ] [10.1016/j.ejmech.2021.113159 ]